IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
Current Issue
Article In Press
Prevalence and Risk Factors of Occupation Induced Asthma among Traffic Police in Bangalore City
Prevalence and Risk Factors of Occupation Induced Asthma among Traffic Police in Bangalore City
o Estimate the Prevalence of Depression, Anxiety, and Stress among Adolescents in Kancheepuram District, Tamil Nadu
A Study on Risk Factors of Anaemia among Pregnant Women
n Approach of Nutritional Deficiency Disorder among Pregnant Women
The Determinants of Self Care Practices By Using DSME to Facilitate the Patients In Kanchipuram District
An evaluation of Epidemiological Factors Relating to Overweight, Obesity in Urban Chennai
A study on the Pattern of Body Image Perception among Adolescents in Urban Chennai
mpact of an External and Internal factors of overweight and obesity in urban
A study on Anti-Rabies Vaccine among Dog Bite Victims in chennai region
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Infusion therapy of experimental hemolytic anemia with a new domestic drug

Author: SHARIFA FAZILOVA, KHAMID YAKUBOVICH KARIMOV, TIMUR RAUFOVICH ALIMOV
Abstract: The use of traditional infusion-transfusion therapy is not always able to fully restore the body and prevent the development of irreversible changes in hemolytic anemia. The aim of the study was to evaluate the effectiveness of the new infusion drug "Reomannisol" in experimental hemolytic anemia. The model of hemolytic anemia was reproduced on 60 rats. Infusion drug "Reomannisol" and comparison drug "Reosorbilact" were administered in a dose of 10 ml/kg of animal weight the next day after the administration of phenylhydrazine for 5 days. The studies were performed in 1 - 2 - 5 days after the drug administration. Demonstrated decrease of endogenous intoxication markers when using "Reomannissol" indicated its efficacy.
Keyword: "Reomannisol", experimental hemolytic anemia, phenylhydrazine, endogenous intoxication.
DOI: https://doi.org/10.31838/ijpr/2019.11.03.113
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus